Production of leukotriene C4 by peripheral blood leukocytes stimulated with anti-IgERI antibody, PMA, and fMLP do not correlate with the degree of irreversible bronchoobturation in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 354s Year: 2004
Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
Pentoxifylline (PTX) inhibits angiogenesis induced by human peripheral blood mononuclear cells (PBMC) and decreases the release of TNFα not influencing IFNγ release Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
Lipopolysaccharide (LPS) inhalation causes an increase in activated neutrophils and lymphocytes Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001
Sulfidoleukotrienes (sLT) production in vitro by blood leucocytes in asthmatic patients treated with theophylline (T) Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001
The relationship between PBMC secretion of IFN-alpha following stimulation by Poly (I:C) and clinical indices in COPD Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Lysis with saponin improves detection of the response through CD203c and CD63 in the basophil activation test after crosslinking of FcεRI Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005
Oncostatin M production and release by FMLP and IL-8 stimulated neutrophils Source: Eur Respir J 2004; 24: Suppl. 48, 550s Year: 2004
Phosphodiesterase 4 inhibition of β2-integrin adhesion caused by leukotriene B4 and TNF-α in human neutrophils Source: Eur Respir J 2006; 28: 920-928 Year: 2006
Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001
The novel phosphodiesterase 4 inhibitor CI-1044 inhibits in vitro LPS-induced TNFα production in whole blood of COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001
The effect of metabolite 1 of erdosteine on the elatase release from human neutrophils Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Ethanol (EtOH) causes bronchoconstriction and plasma protein extravasation (PPE) in rodent airways via vanilloid receptor 1 (VR1) activation Source: Eur Respir J 2002; 20: Suppl. 38, 485s Year: 2002
Ionomycin stimulates a synergistic effect of IL-8 and induced sputum on PMN chemotaxis during COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Suppression of basophil activation via histamine receptor 2 (HR2) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005
Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003
N-formyl Met-Leu-Phe (fMLP), a microbe-derived chemoattractant for leukocytes, activates porcine airway submucosal gland acinar cells Source: Eur Respir J 2001; 18: Suppl. 33, 406s Year: 2001
Phosphodiesterase 4-5 inhibitor (LASSBio596) per os avoided pulmonary mechanical impairment and inflammation produced by microcystin-LR Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009
Airway responsiveness to capsaicin (C), but not to methacholine (M), is influenced by gastric acid secretion inhibition Source: Eur Respir J 2005; 26: Suppl. 49, 278s Year: 2005